Barbara J. Mcneil

Barbara J. Mcneil discloses dealings in 2 companies, chiefly Edwards Lifesciences Corp and CV Therapeutics Inc. In total, 31 filings cover trades dated from 16 February 2006 to 4 February 2016.

The open-market side counts 1 purchase for €7,567 alongside 7 sales for €887k. On balance, insiders were net sellers of €880k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 20 share grants and 3 option exercises. So far in 2016, the count stands at no purchases and 1 sale.

The newest entry dates from 8 February 2016: an open-market sale of €300k, in Edwards Lifesciences Corp. The latest purchase dates back some time: it was published 5,458 days ago, on 30 November 2011. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.